SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-035761
Filing Date
2023-10-05
Accepted
2023-10-05 10:00:05
Documents
5
Period of Report
2023-10-05

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 230991
2 formdef14a_001.jpg GRAPHIC 8152
3 formdef14a_002.jpg GRAPHIC 8156
4 proxy_001.jpg GRAPHIC 284834
5 proxy_002.jpg GRAPHIC 277342
  Complete submission text file 0001493152-23-035761.txt   1029337
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39531 | Film No.: 231310012
SIC: 2834 Pharmaceutical Preparations